title: Routine usage of sentinel node biopsy in melanoma management must cease.
authors.affiliation: Department of Research, Australasian College of Cutaneous Oncology, Docklands, Victoria, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Dixon
authors.affiliation: DermOne Dermatology Centre, Department of Dermatology, Irving, TX, U.S.A.
authors.forename: H
authors.initials: H
authors.lastname: Steinman
authors.affiliation: Maffra Medical Group, Maffra, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Anderson
authors.affiliation: Department of Pathology, Australasian College of Cutaneous Oncology, Docklands, Victoria, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Nirenberg
authors.affiliation: Baker IDI Heart and Diabetes Institute, Department of Research, Melbourne, Victoria, Australia.
authors.forename: J
authors.initials: J
authors.lastname: Dixon
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D008545:Melanoma / Q000473:pathology*; D012680:Sensitivity and Specificity; D021701:Sentinel Lymph Node Biopsy / Q000009:adverse effects / Q000706:statistics & numerical data; D012878:Skin Neoplasms / Q000473:pathology*; D019564:Unnecessary Procedures